8-isoprostane levels in serum and bronchoalveolar lavage in idiopathic pulmonary fibrosis and sarcoidosis.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Food and Chemical Toxicology

• Publication date

  2013-11-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1016/j.fct.2013.05.016PMID 23702326
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Idiopathic Pulmonary Fibrosis - Diagnosis and Treatment

  2014cited by this paper
• American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management

  2011cited by this paper
• Aggravation of bleomycin-induced pulmonary inflammation and fibrosis in mice lacking peroxiredoxin I.

  2011cited by this paper
• Systemic oxidative stress in patients with pulmonary sarcoidosis.

  2009cited by this paper
• Lung function in idiopathic pulmonary fibrosis - extended analyses of the IFIGENIA trial

  2009cited by this paper
• Oxidative stress in the pathogenesis of diffuse lung diseases: a review.

  2009cited by this paper
• Serum levels of oxidative stress as a marker of disease severity in idiopathic pulmonary fibrosis.

  2008cited by this paper
• CD8+ T lymphocytes in bronchoalveolar lavage in idiopathic pulmonary fibrosis

  2007cited by this paper
• Exhaled markers of oxidative stress in idiopathic pulmonary fibrosis

  2006cited by this paper
• Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy.

  2005cited by this paper
• Vegetable, Fruit, and Cereal Intake and Risk of Idiopathic Pulmonary Fibrosis in Japan

  2004cited by this paper
• American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors

  2002cited by this paper
• The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease.

  2002cited by this paper
• American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias

  2002cited by this paper
• Role of oxidative stress in pulmonary fibrosis.

  2002cited by this paper
• Isoprostanes: an overview and putative roles in pulmonary pathophysiology.

  2001cited by this paper
• Oxidative stress and regulation of glutathione in lung inflammation.

  2000cited by this paper
• Idiopathic pulmonary fibrosis: Diagnosis and treatment: International Consensus Statement

  2000cited by this paper
• American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS).

  2000cited by this paper
• international consensus statement

  2000cited by this paper
• Reactive oxygen and nitrogen intermediates increase transforming growth factor-beta1 release from human epithelial alveolar cells through two different mechanisms.

  1999cited by this paper
• 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases.

  1998cited by this paper
• Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis.

  1998cited by this paper
• Hydrogen peroxide release by alveolar macrophages from sarcoid patients and by alveolar macrophages from normals after exposure to recombinant interferons alpha A, beta, and gamma and 1,25-dihydroxyvitamin D3.

  1987cited by this paper
• Responsible Editor: Michael Parnham.

  year unknowncited by this paper

• Locomotor muscle dysfunction and rehabilitative exercise training in fibrotic interstitial lung disease: Where are we at and where could we go?

  2025cites this paper
• Peripheral Levels of Selected Biomarkers in Patients with Post-Sarcoidosis Chronic Fatigue Syndrome

  2025cites this paper
• Characterization of Lipid Epi-Metabolites/Reactions as Diagnostic Biomarkers for Idiopathic Pulmonary Fibrosis by Lipidepifind.

  2025cites this paper
• An Explicative Review on Nanotechnology-based Drug Delivery Systems for Alleviating Oxidative Stress-driven Pathologies.

  2025cites this paper
• Briefing of pulmonary sarcoidosis: Reduction-oxidation, misleading and possibilities.

  2024cites this paper
• Biological and pharmacological roles of pyroptosis in pulmonary inflammation and fibrosis: recent advances and future directions

  2024cites this paper
• Oxidative Stress and Inflammation in Acute and Chronic Lung Injuries

  2023cites this paper
• Thromboxane-Prostanoid Receptor Signaling Drives Persistent Fibroblast Activation in Pulmonary Fibrosis.

  2022cites this paper
• From Biomarker to Mechanism? F2-isoprostanes in Pulmonary Fibrosis

  2022influential citation
• Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis

  2022cites this paper
• Interstitial lung disease and obstructive sleep apnea.

  2021cites this paper
• Oxidative Stress and Endoplasmic Reticulum Stress in Rare Respiratory Diseases

  2021cites this paper
• The F2-Isoprostane:Thromboxane-prostanoid receptor signaling axis drives persistent fibroblast activation in pulmonary fibrosis

  2021cites this paper
• Targeting oxidative stress in disease: promise and limitations of antioxidant therapy

  2021cites this paper
• A Novel UHPLC-MS/MS Method for Measuring 8-iso-Prostaglandin F2α in Bronchoalveolar Lavage Fluid

  2021cites this paper
• Oxidative Stress Induced by Reactive Oxygen Species (ROS) and NADPH Oxidase 4 (NOX4) in the Pathogenesis of the Fibrotic Process in Systemic Sclerosis: A Promising Therapeutic Target

  2021cites this paper
• The Role of Oxidative Stress in Sarcoidosis

  2021cites this paper
• NADPH oxidase-mediated induction of reactive oxygen species and extracellular matrix deposition by insulin-like growth factor binding protein-5.

  2019cites this paper
• The role of measuring exhaled breath biomarkers in sarcoidosis: a systematic review

  2019cites this paper
• Oxidant/Antioxidant Disequilibrium in Idiopathic Pulmonary Fibrosis Pathogenesis

  2019cites this paper
• Features of Oxidative and Nitrosative Metabolism in Lung Diseases

  2019cites this paper
• Exhalative Breath Markers Do Not Offer for Diagnosis of Interstitial Lung Diseases: Data from the European IPF Registry (eurIPFreg) and Biobank

  2019cites this paper
• Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review

  2018cites this paper
• F2‐isoprostanes can mediate bleomycin‐induced lung fibrosis

  2018influential citation
• Detection of mitochondrial transfer RNA (mt-tRNA) gene mutations in patients with idiopathic pulmonary fibrosis and sarcoidosis.

  2018cites this paper
• Nutritional status in patients with Idiopathic Pulmonary Fibrosis

  2018cites this paper
• Oxidative stress-linked biomarkers in idiopathic pulmonary fibrosis: a systematic review and meta-analysis.

  2018cites this paper
• Increased Risk of Atherosclerosis in Patients with Sarcoidosis

  2017cites this paper
• Current concepts of idiopathic pulmonary fibrosis : focus on biomarkers

  2017cites this paper
• Areca nut components stimulate ADAM17, IL-1α, PGE2 and 8-isoprostane production in oral keratinocyte: role of reactive oxygen species, EGF and JAK signaling

  2016cites this paper
• A functional proteomics approach to the comprehension of sarcoidosis.

  2015cites this paper
• A system biology study of BALF from patients affected by idiopathic pulmonary fibrosis (IPF) and healthy controls

  2014cites this paper
• Molecular Biomarkers in Interstitial Lung Diseases

  2014cites this paper
• F 2-isoprostanes can mediate bleomycin-induced lung fibrosis

  year unknowninfluential citation